Cogent Biosciences

About:

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Website: https://www.cogentbio.com

Twitter/X: CogentBio

Top Investors: OrbiMed, Wellington Management, F-Prime Capital, Deerfield, Janus Health

Description:

Cogent Biosciences uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its antibody-coupled T-cell receptor technology, is expected to enter Phase I clinical testing in the coming months to assess safety and efficacy.